Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CDC25B | P30305 | 2/20 | 0.50 |
| ▸ | S100A4 | P26447 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | APAF1 | O14727 | 2/20 | 0.47 |
| ▸ | TDP2 | O95551 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29385474 | 1.00 | MAOA (0.56) | MAOAMAOBCYP2A6CES1MEN1 | |
| Water SCHEMBL460840 | 0.97 | MAOA (0.54) | MAOAMAOBCYP2A6CES1MEN1 | |
| SCHEMBL31157901 | 0.84 | CES1 (0.62) | MAOAMAOBCYP2A6CES1BCHE | |
| Acetic Acid SCHEMBL29684240 | 0.84 | NOTUM (0.52) | MAOAMAOBCYP2A6CES1MEN1 | |
| SCHEMBL2686810 | 0.84 | CES1 (0.62) | MAOAMAOBCYP2A6CES1BCHE | |
| SCHEMBL1268680 | 0.83 | MAOA (0.74) | MAOAMAOBCYP2A6CES1BCHE | |
| SCHEMBL29353311 | 0.83 | MAOA (0.74) | MAOAMAOBCYP2A6CES1BCHE | |
| SCHEMBL24746 | 0.83 | MAOA (0.74) | MAOAMAOBCYP2A6CES1BCHE | |
| SCHEMBL31454252 | 0.81 | MAOA (0.71) | MAOAMAOBCYP2A6CES1BCHE | |
| SCHEMBL16552853 | 0.81 | MAOA (0.71) | MAOAMAOBCYP2A6CES1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240136561-A1 | ELECTRICAL REGENERATION OF ELECTROLYTES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-04-25 | — | — | US | claimed |
| EP-4292156-A1 | ELECTRICAL REGENERATION OF ELECTROLYTES | President and Fellows of Harvard College (US) | 2023-12-20 | — | — | EP | claimed |
| CN-116964799-A | Electric regeneration of electrolytes | 哈佛大学校长及研究员协会 | 2023-10-27 | — | — | CN | claimed |
| WO-2022174088-A1 | ELECTRICAL REGENERATION OF ELECTROLYTES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-18 | — | — | WO | claimed |
| CN-110254025-B | Copper-clad plate production treatment process | 江西省航宇新材料股份有限公司 | 2021-01-15 | — | — | CN | claimed |
| EP-3097904-B1 | DEPIGMENTING AGENTS TO LIGHTEN THE SKIN | AFFICHEM (FR) | 2019-08-14 | — | — | EP | claimed |
| US-20180221426-A1 | Compositions and Methods for Treating and Removing Seborrheic Keratoses | STOECKER WILLIAM VAN DOVER (US) | 2018-08-09 | — | — | US | claimed |
| WO-2018145105-A1 | COMPOSITIONS AND METHODS FOR TREATING AND REMOVING SEBORRHEIC KERATOSES | STOECKER MD WILLIAM VAN DOVER (US) | 2018-08-09 | — | — | WO | claimed |
| EP-2257515-B1 | 1,4-NAPHTHOQUINONE DERIVATIVES AND THERAPEUTIC USE THEREOF | CENTRE NAT RECH SCIENT (FR) | 2017-05-17 | — | — | EP | claimed |
| WO-2016193220-A1 | SKIN PIGMENTATION MODIFIERS TO DARKEN OR LIGHTEN THE SKIN | AFFICHEM (FR) | 2016-12-08 | — | — | WO | claimed |
| US-20040234945-A1 | Fluorimetric determination of analytes by an intramolecular quencher-fluorophore conjugate | ROCHE DIAGNOSTICS GMBH (DE) | 2004-11-25 | — | — | US | claimed |
| WO-2002068056-A2 | COMBINATION COMPRISING A 1,4-DIOXONAPHATHALENE COMPOUND AND RIBENOSIDE | KS BIOMEDIX HOLDINGS PLC (GB) | 2002-09-06 | — | — | WO | claimed |
| US-6342319-B1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, NEGATIVE ELECTRODE OF CARBON | KABUSHIKI KAISHA TOSHIBA (JP) | 2002-01-29 | — | — | US | claimed |
| JP-3251582-B2 | — | — | 2002-01-28 | — | — | JP | claimed |
| EP-0820985-B1 | Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 2000-08-30 | — | — | EP | claimed |
| EP-0570414-B1 | NAPHTHOQUINONE DERIVATIVES FOR THE TREATMENT OF CHRONIC INFLAMMATION | KS BIOMEDIX LTD (GB) | 2000-07-05 | — | — | EP | claimed |
| US-5854273-A | Bisimide compounds | ADIR ET COMPAGNIE (FR) | 1998-12-29 | — | — | US | claimed |
| EP-0570414-A1 | NAPHTHOQUINONE DERIVATIVES FOR THE TREATMENT OF CHRONIC INFLAMMATION | KS BIOMEDIX LTD. (GB) | 1993-11-24 | — | — | EP | claimed |
| WO-1992013532-A2 | NAPHTHOQUINONE DERIVATIVES FOR THE TREATMENT OF CHRONIC INFLAMMATION | CHAYEN JOSEPH (GB) | 1992-08-20 | — | — | WO | claimed |
| EP-0300218-A1 | Use of substituted 1,4-naphthoquinones against nites and fungi | BAYER AG (DE) | 1989-01-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180221426-A1 | Compositions and Methods for Treating and Removing Seborrheic Keratoses | CAT, CUTA, GPX1 | MAOA 2118/4885MAOB 2041/4885CYP2A6 2477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.